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Background. Heifers that reach puberty at an earlier age are more likely to rebreed and
maintain a yearly calving interval than those that reach puberty at a later age. In general, heifers
that gain weight rapidly will attain puberty at an earlier age than contemporary heifers that
experience lower rates of gain. Two major hormones that affect rate of gain are growth hormone
and insulin-like growth factor-I (lGF-I). When growth hormone binds to its receptor in the liver,
it stimulates the production and secretion of IGF-I. Both growth hormone and IGF-I have
beneficial effects on development of bone, muscle, and fat, and increased circulating
concentrations of IGF-I have been positively correlated with improved reproduction. Cattle-
Ase™ is a fibrolytic enzyme preparation that is available in both liquid and dried forms. It has
previously been shown to improve diet digestibility and increase milk production in dairy cows.
It was our hypothesis that ingestion of Cattle-Ase™ would increase circulating concentrations of
IGF-I, and enhance growth and possibly puberty attainment. We initiated two experiments, one
on pasture and one in drylot, to ascertain the effects of Cattle-Ase™ on growth of prepuberal
heifers.
Research Findings. In trial I (TRI), Cattle-Ase™ was delivered in a commercial
molasses-urea lick tank (24% CP with 18% NPN, 3% fat) to 54 fall-born, prepuberal, crossbred
heifers grazing coastal bermudagrass (CBG) for 84 d. Heifers were assigned to two replicate
pastures according to breedtype, age, and body weight (BW): 1) pasture only (P), 2) P +
molasses-urea lick (M), and 3) P + M + Cattle-Ase™ (MC). Cattle-Ase™ was added at a
minimum rate of 30 gl19 Ibs to a maximum rate of 60 gill Ibs molasses. Average molasses
consumed was 2.53 Ibslhd/d; thus, average urea intake was -.46 Ibslhd/d. Weights and body
condition scores (BCS) were recorded at initiation and 28-day intervals in TR I, with blood
samples collected at initiation and weekly. Serum samples from TRI were assayed for
concentration of IGF-I by RIA. There was no treatment effect (P > .10) on BW, BCS, or serum
concentrations of IGF-I throughout TRl, nor was there an effect on ADG (P=,36) with ADG as
follows: 1.19, 1.43, 1.41 ± .13 Ibs/hdld for P, M, Me, respectively (Figure 1).
In trial 2 (TR2), heifers from TR 1 were reassigned to two treatments: 1) Cattle-Ase
(CSE) and 2) control (C). The MC heifers were assigned to CSE, M heifers assigned to C, and P
heifers were divided equally between treatments. Heifers had ad libitum access to CBG hay and
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were group fed 2: 1 com:soybean meal (33% CP) at 1% BW, with Cattle-Ase™ provided to CSE
heifers at 1.85 glhd/d for 126 d. Supplement was adjusted for changing BW each 28 d. Weights
and body condition scores were recorded at initiation and biweekly in TR2, with blood samples
collected at initiation and weekly. In TR2, Cattle-Ase™ increased ADG (P < .04). The CSE
heifers gained .92 ± .07 Ibs/hd/d compared to C heifers that gained .75 ±.04 Ibs/hd/d (Figure 2).
Application. The effects of Cattle-Ase™ ingestion may be dependent upon a variety of
factors such as the carrier, the amount of non-protein nitrogen consumed, and/or the forage
source. These studies demonstrated that addition of Cattle-Ase™ to molasses-urea lick tanks did
not improve ADG of prepuberal heifers grazing coastal bermudagrass pastures; however, addition
of Cattle-Ase™ to a dry supplement when heifers consumed coastal bermudagrass hay increased
ADG. While not confirmed with these data, the increase in ADG when Cattle-Ase™ was fed in






















Figure 1. Average daily gain of heifers
During Trial 1.
Figure 2. Average daily gain of heifers
During Trial 2.
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